Skip to content
← Back to this collection

PUBLICATIONS · 10717522

Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2000 Mar
First author
Behnia M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2000 Mar;36(4):440-2. doi: 10.1016/s0959-8049(00)00035-6.
    note
    Source null
    related pmid
    10717517
    relationship
    Comment in

Authors and identifiers

  1. name
    Behnia M
    type
    Author
  2. name
    Foster R
    type
    Author
  3. name
    Einhorn LH
    type
    Author
  4. name
    Donohue J
    type
    Author
  5. name
    Nichols CR
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Behnia M
    type
    Author
  2. name
    Foster R
    type
    Author
  3. name
    Einhorn LH
    type
    Author
  4. name
    Donohue J
    type
    Author
  5. name
    Nichols CR
    type
    Author
bibliography ids
  1. nci-bib-c6a5e40904cc5fddd47d0593
book metadata
content sha256
5566d44b498587e14de770dfd36c6e0c9096a02e57a75cff5fd56f2317ca45a5
document type
citation
dois
  1. 10.1016/s0959-8049(99)00316-0
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:10717522
immutable id
pubmed:10717522@5566d44b498587e14de770dfd36c6e0c9096a02e57a75cff5fd56f2317ca45a5
journal
abbreviation
Eur J Cancer
issn electronic
Source null
issn print
0959-8049
issue
4
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
472-5
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2000 Mar;36(4):440-2. doi: 10.1016/s0959-8049(00)00035-6.
    note
    Source null
    related pmid
    10717517
    relationship
    Comment in
outcomes validated
false
pmid
10717522
provenance
batch id
40703d4bdd5a70d2c67a
provider
NCBI PubMed ESummary
record sha256
e03fb0cf19b68e17b4e2ed76dcbf4eb83b9b437706a7ec7dc8b31b420af5660d
response sha256
a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
retrieved at
2026-09-09T23:45:35.800055+00:00
publication date
display
2000 Mar
precision
month
year
2000
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
  3. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/10717522/
title
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.

Preserved source evidence · Not medical advice